FIELD: medicine, microbiology, pharmacology.
SUBSTANCE: invention proposes a medicinal preparation for treatment of muscular dystonia that comprises botulinic toxin isolated from culture Clostridium botulinum as a liquid substance dissolved mainly in 0.87% physiological solution with albumin. Method for preparing the preparation involves preparing botulinic toxin from culture Clostridium botulinum by culturing its strain at temperature 29-33°C for 3-6 days in nutrient medium. Then dry ammonium sulfate is added to cultural fluid slowly for formation of precipitate. Prepared suspension is centrifuged for preparing precipitate and isolated liquid phase is extracted and subjected for purification. Process for purifying the liquid substance of medicinal preparation is carried out for two stages using metal sorbent at the first stage and gel-filtration at pH 5.5-6.0 - at the second stage. Sterilization of the purified substance is carried out by membrane filtration. Invention provides preparing the preparation with reduced risk for arising intolerance and with high stability in storage.
EFFECT: improved method for preparing, valuable medicinal properties of preparation.
6 cl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICINAL PREPARATION FOR TREATMENT OF MUSCLE DYSTONIA AND METHOD FOR ITS PREPARING | 2002 |
|
RU2206337C1 |
METHOD FOR PRODUCTION OF NEUROMUSCULAR RELAXANT DRUG FOR TREATMENT OF MUSCLE DYSTONIAS | 2005 |
|
RU2292910C2 |
METHOD FOR PREPARING PURIFIED PREPARATION OF BOTULINIC TOXIN TYPE A | 2002 |
|
RU2230325C2 |
METHOD FOR BOTULINUM TOXIN PRODUCTION | 2014 |
|
RU2627159C2 |
STRAIN OF HYBRID CELLS OF ANIMALS Mus musculus 3F11 - PRODUCER OF MONOCLONAL ANTIBODIES SPECIFIC TO BOTULINUS TOXIN TYPE B | 2014 |
|
RU2566553C1 |
METHOD OF OBTAINING BOTULINUM NEUROTOXIN (VERSIONS) | 2010 |
|
RU2561459C2 |
TOXIN PRODUCTION METHOD | 2020 |
|
RU2789552C1 |
COMPOSITION OF THE CULTURE MEDIUM | 2020 |
|
RU2782793C1 |
LIQUID COMPOSITION OF NEUROTOXIN STABILIZED WITH TRYPTOPHAN OR TYROSINE | 2017 |
|
RU2741497C2 |
STRAIN OF HYBRID ANIMAL CELLS Mus musculus 1G7 - PRODUCER OF MONOCLONAL ANTIBODIES SPECIFIC FOR BOTULINUM TOXIN OF TYPE B | 2014 |
|
RU2571208C1 |
Authors
Dates
2005-07-10—Published
2004-07-01—Filed